You are currently browsing the archives for 30 March 2018.
Displaying 1 entry.

Antiretroviral syrup for babies.

Among infants who were HIV-free at one week old, 6.4 % on the improved control arm were infected by 28 weeks, compared to 3.0 % of the infants on the maternal treatment arm and 1.8 % of the infants who received daily nevirapine syrup. Upon examining the probability of HIV contamination or death by 28 weeks postpartum, 7.6 % of the infants on the enhanced control arm were HIV-infected or died compared to 4.7 % of the infants on the maternal treatment arm, and 2.9 % of the infants on the newborn prophylaxis arm. The BAN study results give global and national policy makers the decision which intervention to put into action based on the conditions and resources in their particular establishing. We hope to see these results translated quickly into plan and policy.. Antiretroviral syrup for babies, mothers safely reduces HIV transmission Giving daily antiretroviral syrup to breastfeeding infants or dealing with their HIV-contaminated mothers with highly energetic antiretroviral drugs is safe and effective in preventing mother-to-child HIV transmission through breast milk, a scholarly research led by University of NEW YORK at Chapel Hill investigators offers found.